Medications

Breast cancer medication risk

New research led by Flinders University has found a link between beta-blockers and survival outcomes in some breast cancer patients.

Diseases, Conditions, Syndromes

Addition of zinc may benefit some being treated for COVID-19

(HealthDay)—For hospitalized patients with COVID-19, the addition of zinc sulfate to hydroxychloroquine and azithromycin may improve some outcomes, according to a study not yet peer reviewed and posted on medRxiv.org.

Medical research

Patients improve after heart cell therapy

Four of six critically ill COVID-19 (coronavirus) patients significantly improved after receiving an experimental therapeutic designed to reduce inflammation, a major cause of death from this disease, according to a case ...

Diseases, Conditions, Syndromes

NIH clinical trial of remdesivir to treat COVID-19 begins

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University ...

Diseases, Conditions, Syndromes

Blood pressure drug linked to lower risk of gout

Affecting more than 7 million adults in the United States, gout is characterized by a sudden onset of pain, swelling and stiffness in the joints and caused by the formation of urate crystal in small spaces between joints ...

page 7 from 14